Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CTi Biopharma Corp (NASDAQ:CTIC)

U.S. Markets are not yet open, but CTIC is being traded in the pre-market session. Pre-Market quote »
1.12
Delayed Data
As of Feb 05
 -0.02 / -1.75%
Today’s Change
0.80
Today|||52-Week Range
2.94
-8.94%
Year-to-Date

Today’s Trading

Previous close1.14
Today’s open1.13
Day’s range1.12 - 1.16
Volume765,997
Average volume (3 months)1,640,470
Market cap$314.1M
Dividend yield--
Data as of 02/05/2016

Growth & Valuation

Earnings growth (last year)-51.16%
Earnings growth (this year)+19.23%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+73.24%
P/E ratioNM
Price/Sales5.83
Price/Book4.74

Competitors

 Today’s
change
Today’s
% change
NEONeogenomics Inc-0.25-3.94%
RDNTRadNet Inc-0.43-7.68%
NVTAInvitae Corp0.000.00%
GNMKGenMark Diagnostics ...-0.42-7.64%
Data as of 02/05/2016

Financials

Next reporting dateFebruary 17, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$60.1M
Annual profit (last year)-$93.4M
Net profit margin-155.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Bianco
Executive Vice President-Finance &
Administration
Lou A. Bianco
Corporate headquarters
Seattle, Washington

Forecasts

Partner Offers